351490-85-2

Usage

Uses

Used in Organic Chemistry:
1H-Indene-2-ethanamine, 2,3-dihydro-.alpha.,.alpha.-dimethylis used as a building block for the synthesis of more complex organic molecules. Its unique structural features make it a valuable intermediate in the preparation of various organic compounds.
Used in Pharmaceutical Industry:
1H-Indene-2-ethanamine, 2,3-dihydro-.alpha.,.alpha.-dimethylis used as a potential candidate for the development of new drugs. Its amine functionality and structural characteristics can be exploited to design and synthesize novel therapeutic agents with potential applications in various medical fields.
Used in Research:
1H-Indene-2-ethanamine, 2,3-dihydro-.alpha.,.alpha.-dimethylis used as a research compound to study its chemical properties, reactivity, and potential interactions with other molecules. This can provide valuable insights into its behavior and possible applications in various scientific and industrial processes.

Upstream product

• 53273-37-3 indan-2-yl-acetic acid methyl ester 
• 351490-86-3 1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-ol 
• 37868-26-1 2-(indan-2-yl)acetic acid 
• 351490-87-4 N-(1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl)acetamide 

Downstream Products

• 702687-43-2 (R)-1-(5-bromo-2,3-difluoro-phenoxy)-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propan-2-ol 
• 351490-26-1 SB-423557 
• 1232402-91-3 3-{2-[(1R)-1-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}ethyl]phenyl}propanoic acid 
• 1232407-05-4 methyl 3-{2-[(1R)-1-({(5R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]-2-oxo-1,3-oxazolidin-5-yl}methoxy)ethyl]phenyl}-2,2-dimethylpropanoate 
• 1232407-04-3 Methyl 3-(2-[(1R)-1-({(5R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]-2-oxo-1,3-oxazolidin-5-yl}methoxy)ethyl]phenyl}-2-methylpropanoate 
• 1232407-03-2 methyl 3-{2-[(1R)-1-({(5R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]-2-oxo-1,3-oxazolidin-5-yl}methoxy)ethyl]phenyl}propanoate 
• 1232407-01-0 3-{2-[(1R)-1-{[(2R)-3-{[1-(2,3-Dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}ethyl]phenyl}-2,2-dimethylpropanoic acid 
• 1232402-97-9 methyl 3-{2-[(1R)-1-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}ethyl]phenyl}propanoate 
• 1035154-06-3 ethyl 3-[3-((1S)-2-{[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino}-1-hydroxyethyl)-4,5-difluorophenyl]propanoate 
• 862992-88-9 (R)-1-(6-bromo-2,3-difluoro-phenoxy)-3-(2-indan-2-yl-1,1-dimethylethylamine)-propan-2-ol 
• 862992-95-8 3-bromo-2-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-benzonitrile 

Relevant academic research and scientific papers

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS

Novel tricyclic compounds of Formula (I) and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing osteoporosis and similar conditions. The compounds are effective as calcium sensing receptor antagonists. Pharmaceutical compositions and methods of treatment are also included.

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OSTEOPOROSIS

Novel tricyclic compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing osteoporosis and similar conditions. The compounds are effective as calcium sensing receptor antagonists. Pharmaceutical compositions and methods of treatment are also included.

SULFONAMIDE COMPOUNDS AND THE USE

The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.

Calcilytic compounds

Novel phosphate esters compounds and methods of using them as calcilytic compounds are provided.

Calcilytic compounds

Novel calcilytic compounds and methods of using them are provided.

Calcilytic compounds

Novel calcilytic compounds and methods of using them are provided.